Cytokinetics Inc (CYTK) — 8-K Filings

8-K Filings (28)

• Cytokinetics Files 8-K — Dec 19, 2025 Risk: low
  Cytokinetics, Incorporated filed an 8-K on December 19, 2025, reporting an event under 'Other Events'. The filing does not contain specific details about the ev
• 8-K Filing — Dec 12, 2025
• 8-K Filing — Nov 14, 2025
• Cytokinetics Reports Material Definitive Agreement & Equity Sales — Sep 22, 2025 Risk: medium
  Cytokinetics, Inc. reported on September 16, 2025, regarding several material events. These include entering into a definitive agreement, creating a direct fina
• Cytokinetics Files 8-K for Other Event — Sep 16, 2025 Risk: medium
  Cytokinetics, Inc. filed an 8-K on September 16, 2025, reporting an "Other Event" as of September 15, 2025. The filing does not contain specific details about t
• Cytokinetics Files 8-K — Sep 3, 2025 Risk: low
  Cytokinetics, Inc. filed an 8-K on September 3, 2025, reporting other events and financial statements as of August 31, 2025. The filing does not contain specifi
• Cytokinetics Files 8-K — Sep 2, 2025 Risk: low
  Cytokinetics, Incorporated filed an 8-K on September 2, 2025, reporting events as of August 30, 2025. The filing primarily concerns financial statements and exh
• Cytokinetics Announces Executive and Board Changes — Aug 20, 2025 Risk: medium
  Cytokinetics, Inc. announced on August 19, 2025, changes in its executive team and board of directors. Specifically, Dr. Fady Malik has been appointed as the Ch
• Cytokinetics Files 8-K on Financials — Aug 7, 2025 Risk: low
  Cytokinetics, Inc. filed an 8-K on August 7, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and
• Cytokinetics Reports on Shareholder Vote Matters — May 16, 2025 Risk: low
  Cytokinetics, Incorporated filed an 8-K on May 16, 2025, reporting an event on May 14, 2025, related to the submission of matters to a vote of security holders.
• Cytokinetics Files 8-K Report — May 1, 2025 Risk: low
  On April 29, 2025, Cytokinetics, Incorporated filed an 8-K report. The filing indicates "Other Events" as the primary item of information. No specific details r
• Cytokinetics Files 8-K for Regulation FD Disclosure — Mar 10, 2025 Risk: low
  On March 10, 2025, Cytokinetics, Incorporated filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure, indicating that
• Cytokinetics Announces Board and Executive Changes — Feb 11, 2025 Risk: medium
  Cytokinetics, Incorporated announced on February 10, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the company
• Cytokinetics Announces Board and Executive Changes — Dec 16, 2024 Risk: medium
  On December 16, 2024, Cytokinetics, Incorporated filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicate
• Cytokinetics Enters Material Definitive Agreement — Nov 19, 2024 Risk: medium
  Cytokinetics, Incorporated announced on November 18, 2024, that it has entered into a Material Definitive Agreement. The filing does not provide specific detail
• Cytokinetics Elects New Directors, Updates Executive Pay — Aug 15, 2024 Risk: low
  Cytokinetics, Incorporated announced on August 13, 2024, changes in its board of directors and executive compensation arrangements. Specifically, the company el
• Cytokinetics Files 8-K on Financials — Aug 8, 2024 Risk: low
  Cytokinetics, Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and
• Novo Nordisk to Acquire Cytokinetics for $5.7 Billion — Jun 7, 2024 Risk: medium
  Cytokinetics, Inc. announced on June 7, 2024, that it has entered into a definitive agreement to be acquired by a subsidiary of Novo Nordisk A/S for $5.7 billio
• Cytokinetics Files 8-K for Regulatory Disclosure — Jun 5, 2024 Risk: low
  Cytokinetics, Incorporated filed an 8-K on June 5, 2024, to report on events that require disclosure under Regulation FD and to file financial statements and ex
• Cytokinetics Files 8-K — May 28, 2024 Risk: low
  Cytokinetics, Inc. filed an 8-K on May 28, 2024, to report other events and financial statements. The filing does not contain specific details about new materia
• Amgen Completes Acquisition of Cytokinetics — May 22, 2024 Risk: medium
  Cytokinetics, Inc. announced on May 22, 2024, the completion of its acquisition by Amgen Inc. The transaction, which was previously announced, has now been fina
• Cytokinetics Adds New Directors, Realigns Board Committees — May 17, 2024 Risk: low
  On May 15, 2024, Cytokinetics, Incorporated filed an 8-K report detailing several key events. The company announced the election of two new directors, Dr. Andre
• Cytokinetics Files 8-K: Financial Statements and Exhibits — May 13, 2024 Risk: low
  On May 13, 2024, Cytokinetics, Incorporated filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material even
• Cytokinetics Files 8-K — May 8, 2024 Risk: low
  Cytokinetics, Inc. filed an 8-K on May 8, 2024, reporting an "Other Event." The filing does not contain specific details about the event itself, but it confirms
• Cytokinetics Announces Board Changes and Executive Compensation Updates — Apr 26, 2024 Risk: low
  On April 23, 2024, Cytokinetics, Incorporated announced changes in its board of directors and executive compensation. Specifically, Dr. Robert E. Conway and Ms.
• Cytokinetics Files 8-K: Other Events Reported — Apr 5, 2024 Risk: low
  Cytokinetics, Incorporated filed an 8-K on April 5, 2024, to report other events. The filing does not contain specific details about the nature of these events,
• Cytokinetics Files 8-K for Financial Results and Operations — Feb 27, 2024 Risk: medium
  Cytokinetics, Incorporated filed an 8-K on February 27, 2024, to report on its results of operations and financial condition. This standard disclosure also incl
• CYTOKINETICS: Officer Compensation Arrangements Updated Jan 29 — Feb 2, 2024
  Cytokinetics, Incorporated filed an 8-K on February 2, 2024, reporting an event that occurred on January 29, 2024, related to changes in compensatory arrangemen

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX